Robert Woodburn, MD
Radiation Oncology · Merrillville, INNPI 1407848849
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $723 and has fallen 92.2% since, to $57 in 2025.
Across 73 payments — averaging $29.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zap Surgical Systems, Inc.$409
- Myriad Genetic Laboratories, Inc.$231
- Elekta, Inc.$187
- Gilead$117
- Medtronic$106
- Novocure Inc.$104
- plus $998 from 26 others
What the payments were for
- Food & beverage$2,08897%
- Education$653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zap Surgical Systems, Inc. | 6 | $409 |
| Myriad Genetic Laboratories, Inc. | 6 | $231 |
| Elekta, Inc. | 1 | $187 |
| Gilead(2 entities) | 5 | $117 |
| Medtronic(2 entities) | 4 | $106 |
| Novocure Inc. | 6 | $104 |
| Beigene USA, Inc. | 4 | $99 |
| Seagen Inc. | 2 | $85 |
| Novartis | 3 | $75 |
| Siemens Medical Solutions USA, Inc. | 3 | $68 |
| AstraZeneca | 4 | $67 |
| Blue Earth Diagnostics | 3 | $59 |
| Cardinal Health 414 LLC | 3 | $53 |
| Boston Scientific | 1 | $44 |
| Bayer | 2 | $43 |
| Amgen | 2 | $39 |
| Lundbeck LLC | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Beone Medicines USA, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Sobi, Inc | 1 | $27 |
| GT Medical Technologies, Inc | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $22 |
| Myovant Sciences Inc. | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Pfizer | 1 | $18 |
| Tolmar Pharmaceuticals, Inc. | 1 | $16 |
| Livanova USA, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,153 in reported general payments places this provider in the 80th percentile of 116 radiation oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 11 | $79 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Merrillville
- Ram NarayanMerrillville$2K
- Brian ChangFort Wayne$13K
- Michael EatonIndianapolis$11K
- William PorterMadison$8K
- Binh TranMishawaka$7K
- Gordon WatsonIndianapolis$6K
- John CoxIndianapolis$5K
- Houman VaghefiGoshen$5K
- Peter GarrettIndianapolis$5K
- Garrett JensenIndianapolis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.